Inspire 10-Q Details $24.4M Q3 Loss on $24.1M Restructuring, $7.0M Legal Settlement
INSP sits 72% above its 52-week low of $38.91.
Summary
Inspire's Q3 10-Q shows revenue down 7.9% to $206.7 million and a $24.4 million net loss driven by $24.1 million of restructuring charges and a $7.0 million legal settlement, with coding and reimbursement problems still weighing on U.S. sales.
Key Events · Earnings and Guidance · INSP
-
Q3 Revenue Falls 7.9% to $206.7M
Revenue was $206.7 million versus $224.5 million a year ago, with U.S. revenue down 7.9% to $197.5 million on coding and reimbursement challenges for Inspire V.
-
Net Loss on Restructuring and Settlement
Net loss was $24.4 million, or $(0.84) per diluted share, versus $9.9 million of net income a year ago, after $24.1 million of Project Horizon restructuring charges and $7.0 million of legal settlement expense.
-
Impairment Is Non-Cash
Of the $24.1 million restructuring charge, $21.1 million is a non-cash write-down of production equipment tied to ceasing certain manufacturing activities; severance was $3.1 million.
-
Liquidity Remains Strong
Cash and cash equivalents were $190.8 million with $262.3 million of investments at September 30, 2026, and operating cash flow was $82.5 million for the nine months versus $64.5 million a year ago.
Analysis · INSP · Industrial Applications And Services
The 10-Q fills in the numbers behind this morning's earnings release, and the headline is a swing to a $24.4 million net loss, or $(0.84) per diluted share, from $9.9 million of net income a year ago, as revenue fell 7.9% to $206.7 million. Most of the damage is one-time: $24.1 million of Project Horizon restructuring charges, of which $21.1 million is a non-cash write-down of production equipment, plus a $7.0 million settlement of the website pixel-tracking class action. Strip those out and adjusted EPS was $0.14. The real problem is the top line, where U.S. revenue dropped 7.9% on coding and reimbursement confusion around Inspire V, and management expects that pressure to persist through the rest of 2026. The balance sheet is not the issue, with $190.8 million of cash plus $262.3 million of investments and $82.5 million of operating cash flow through nine months. The legal overhang is: the securities class action was amended to add Medicare/CPT coding fraud claims, with a motion to dismiss hearing set for February 2027, and a DOJ False Claims Act investigation remains open with no loss accrued.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INSP was trading at $67.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $38.91 to $147.03. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.